Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Nov 17:13:1021704.
doi: 10.3389/fendo.2022.1021704. eCollection 2022.

Adrenal insufficiency in patients with Prader-Willi syndrome

Affiliations
Review

Adrenal insufficiency in patients with Prader-Willi syndrome

Marcin Jerzy Kusz et al. Front Endocrinol (Lausanne). .

Abstract

The generalized dysfunction of the hypothalamic-pituitary axis in patients with Prader-Willi syndrome (PWS) is the most likely cause of hypogonadism, inadequate growth hormone secretion, excessive appetite and associated obesity, impaired body temperature regulation, and hypothyroidism. The syndrome is also related to an increased risk of central adrenal insufficiency, although its prevalence remains unknown. The results of the studies in which different methods of pharmacological stimulation were used do not provide conclusive outcomes. As a result, there are no clear guidelines with regard to diagnosis, prevention, or long-term care when adrenal insufficiency is suspected in patients with PWS. Currently, most patients with PWS are treated with recombinant human growth hormone (rhGH). It has been confirmed that rhGH therapy has a positive effect on growth, body composition, body mass index (BMI), and potentially on psychomotor development in children with PWS. Additionally, rhGH may reduce the conversion of cortisone to cortisol through inhibition of 11β-hydroxysteroid dehydrogenase type 1. However, its influence on basal adrenal function and adrenal stress response remains unexplained in children with PWS. This paper reviews the literature related to the hypothalamic-pituitary-adrenal axis dysfunction in the PWS patient population with a focus on children.

Keywords: LDSST; PWS; Prader-Willi syndrome; Synacthen; adrenal insufficiency.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References

    1. Prader A, Labhart A, Willi H. Ein syndrome von adipositas, kleinwuchs, kryptorchismus und oligophrenie nach myotonieartigem zustand im neugeborenenalter. Schweiz. Med Wochenschr (1956) 86:1260–1.
    1. Butler MG, Miller JL, Forster JL. Prader-willi syndrome - clinical genetics, diagnosis and treatment approaches: An update. Curr Pediatr Rev (2019) 15(4):207–44. doi: 10.2174/1573396315666190716120925 - DOI - PMC - PubMed
    1. Driscoll DJ, Miller JL, Schwartz S, Cassidy SB. Prader-willi syndrome. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Mirzaa G, Amemiya A, editors. GeneReviews. Seattle (WA: University of Washington, Seattle; (1998). - PubMed
    1. Miller JL, Lynn CH, Driscoll DC, Goldstone AP, Gold JA, Kimonis V, et al. . Nutritional phases in prader-willi syndrome. Am J Med Genet A (2011) 155A(5):1040–9. doi: 10.1002/ajmg.a.33951 - DOI - PMC - PubMed
    1. Fermin Gutierrez MA, Mendez MD. Prader-willi syndrome. In: StatPearls. Treasure Island (FL: StatPearls Publishing; (2021). - PubMed

MeSH terms